Literature DB >> 20067465

Cellular context-dependent "colors" of transforming growth factor-beta signaling.

Hiroaki Ikushima1, Kohei Miyazono.   

Abstract

Transforming growth factor (TGF)-beta signaling has interesting characteristics in the context of cancer. Although perturbations of TGF-beta signaling are strongly implicated in cancer progression, TGF-beta signaling has both tumor-suppressive and tumor-promoting effects. For example, TGF-beta inhibits cancer cell proliferation in some cellular contexts, but promotes it in others. Although several approaches to treating cancer have been considered using TGF-beta-based therapeutic strategies, the contradictory behaviors of TGF-beta have made these approaches complex. To put them to practical use, either the tumor-suppressive or tumor-promoting arm needs to be specifically manipulated. However, there is virtually no method to specifically regulate a certain cell response induced by TGF-beta. In this review, we first consider the basic machinery of TGF-beta signaling, and describe several cell responses induced by TGF-beta stimulation in specific contexts. Mechanisms by which TGF-beta can induce several responses in a cellular context-dependent fashion are discussed with established paradigms and models. We also address perspectives on the specific control of only a subset of numerous cell responses induced by TGF-beta stimulation. Such methods will aid specific regulation of either the tumor-suppressive or tumor-promoting arm of the TGF-beta pathway and in realization of TGF-beta-based treatment of malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20067465     DOI: 10.1111/j.1349-7006.2009.01441.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  34 in total

Review 1.  TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis.

Authors:  Rohan Samarakoon; Jessica M Overstreet; Stephen P Higgins; Paul J Higgins
Journal:  Cell Tissue Res       Date:  2011-06-04       Impact factor: 5.249

Review 2.  TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.

Authors:  Elena Gallo MacFarlane; Julia Haupt; Harry C Dietz; Eileen M Shore
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

3.  The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.

Authors:  Shyam Nyati; Katrina Schinske-Sebolt; Sethuramasundaram Pitchiaya; Katerina Chekhovskiy; Areeb Chator; Nauman Chaudhry; Joseph Dosch; Marcian E Van Dort; Sooryanarayana Varambally; Chandan Kumar-Sinha; Mukesh Kumar Nyati; Dipankar Ray; Nils G Walter; Hongtao Yu; Brian Dale Ross; Alnawaz Rehemtulla
Journal:  Sci Signal       Date:  2015-01-06       Impact factor: 8.192

4.  Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.

Authors:  Hiroaki Ikushima; Tomoki Todo; Yasushi Ino; Masamichi Takahashi; Nobuhito Saito; Keiji Miyazawa; Kohei Miyazono
Journal:  J Biol Chem       Date:  2011-10-10       Impact factor: 5.157

5.  The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer.

Authors:  Chandrakanth Are; Neka Simms; Ashwani Rajput; Ashwani Rajupt; Michael Brattain
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

6.  Transformation of SV40-immortalized human uroepithelial cells by 3-methylcholanthrene increases IFN- and Large T Antigen-induced transcripts.

Authors:  Lynn M Crosby; Tanya M Moore; Michael George; Lawrence W Yoon; Marilyn J Easton; Hong Ni; Kevin T Morgan; Anthony B DeAngelo
Journal:  Cancer Cell Int       Date:  2010-02-23       Impact factor: 5.722

7.  Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.

Authors:  Flavia R R Mangone; Fernando Walder; Simone Maistro; Fátima S Pasini; Carlos N Lehn; Marcos B Carvalho; M Mitzi Brentani; Igor Snitcovsky; Miriam H H Federico
Journal:  Mol Cancer       Date:  2010-05-12       Impact factor: 27.401

Review 8.  Notch signaling in glioblastoma: a developmental drug target?

Authors:  Maria Maddalena Lino; Adrian Merlo; Jean-Louis Boulay
Journal:  BMC Med       Date:  2010-11-15       Impact factor: 8.775

9.  Tgfbeta2 and 3 are coexpressed with their extracellular regulator Ltbp1 in the early limb bud and modulate mesodermal outgrowth and BMP signaling in chicken embryos.

Authors:  Carlos I Lorda-Diez; Juan A Montero; Juan A Garcia-Porrero; Juan M Hurle
Journal:  BMC Dev Biol       Date:  2010-06-21       Impact factor: 1.978

10.  Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study.

Authors:  Yinghao Su; Hui Cai; Ying Zheng; Qingchao Qiu; Wei Lu; Xiao Ou Shu; Qiuyin Cai
Journal:  Am J Epidemiol       Date:  2016-09-19       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.